This content is machine translated Prostate cancer and co. The most important congress information at a glance Europe’s largest urology event, the 38th EAU Annual Congress, included live surgeries, cutting-edge lectures, case discussions and debates during the four-day scientific exchange. To emphasize the multidisciplinary nature of urology,…
View Post 3 min This content is machine translated Annual Congress of the American Urological Association (AUA), San Francisco Risk assessment in prostate cancer: what do biomarkers do? Since the implementation of PSA testing, the number of PCa diagnoses has multiplied. Biomarkers are increasingly used to prevent overdiagnosis and overtreatment. New approaches, but also limitations, of microbiological testing…
View Post 8 min This content is machine translated Prostate Cancer Screening Thoughts on optimizing prostate cancer screening. PSA screening reduces prostate cancer-specific mortality. However, measures to optimize screening programs are indicated. The buzzword is “smarter screening.”
View Post 3 min This content is machine translated Multiparametric MRI in prostate cancer. A means to increase diagnostic accuracy Can multiparametric MRI be used in triage to avoid unnecessary prostate biopsies in some individuals and more targeted biopsies in others? According to the results of a British study published…
View Post 8 min This content is machine translated Prostate cancer in old age If “man” gets old enough, prostate cancer is almost inevitable Prostate cancers are very common in older men. The clinical presentation varies widely. In principle, older men can also benefit from treatments.
View Post 6 min This content is machine translated Prostate Cancer News Diagnostics and therapy of today – what is possible, what is new? Patient counseling is becoming increasingly important in prostate cancer. Diagnosis and therapy should be based on medical appropriateness and not primarily on medical options. In the case of carcinoma, up…
View Post 10 min This content is machine translated PSA, CEA, AFP and Co. Practical aspects of the use of tumor markers Tumor screening with tumor markers alone is not useful, except for PSA/prostate cancer. Screening for prostate cancer must be discussed with the patient on an individual basis. Tumor markers can…
View Post 3 min This content is machine translated Prostate cancer risk Bald or not, varied sex life is crucial Epidemiological studies on the association between androgenetic alopecia and risk of prostate cancer are conflicting. Now it has been shown again: Male hair loss is unsuitable as a risk marker.…
View Post 7 min This content is machine translated Active surveillance as a treatment option Status quo and challenges using the example of prostate carcinoma Studies suggest that Active Surveillance is a treatment option for tumors with low risk of progression (low-risk tumors). The treatment team should work with the patient to determine treatment strategies…
View Post 7 min This content is machine translated Prostate Cancer Focal therapy as a new option Focal treatment of prostate cancer is a new strategy that complements the two treatment options of “active surveillance” and radical prostatectomy. The goal is to target the clinically significant tumor…
View Post 4 min This content is machine translated ESMO Congress Aspirin – a miracle drug in the fight against cancer? Evidence is accumulating that Aspirin® may be effective in cancer prevention, as well as in inhibiting metastases. One of the most renowned researchers and best-known representatives of this new optimism…
